Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Cardiology-CTVS
  • Cardiology & CTVS Guidelines
  • Management of Heart...

Management of Heart Failure: ESC Updates Guidelines

Written By : Dr. Kamal Kant Kohli Published On 2023-08-28T10:00:39+05:30  |  Updated On 28 Aug 2023 4:44 PM IST
Management of Heart Failure: ESC Updates Guidelines
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Canada: The European Society of Cardiology (ESC) has taken a significant stride in the field of heart failure management with a focused update to their heart failure guidelines. This update incorporates crucial data from nearly a dozen new clinical trials that have been published since 2021. The trials include notable studies such as EMPEROR-Preserved, DELIVER, STRONG-HF, IRONMAN, and more. The updated guidelines, which were unveiled on the opening day of the ESC Congress 2023, offer novel recommendations related to the use of SGLT2 inhibitors in patients with heart failure and updates on comorbidity management.

New Recommendations:

  • SGLT2 Inhibitors for Heart Failure with Reduced Ejection Fraction (HFmrEF) and Preserved Ejection Fraction (HFpEF): The guidelines now recommend the use of SGLT2 inhibitors (dapagliflozin or empagliflozin) in patients with HFmrEF and HFpEF. This is to reduce the risk of heart failure hospitalization or cardiovascular death. The recommendation is classified as Class I, Level A, signifying a strong endorsement based on robust evidence.
  • Acute Heart Failure Strategy: An intensive approach involving the initiation and rapid up-titration of evidence-based treatment before discharge, along with meticulous follow-up within the initial 6 weeks post-heart failure hospitalization, is recommended. This strategy aims to decrease the risk of heart failure rehospitalization or death and is classified as Class I, Level B.
  • Comorbidities Management: The update addresses heart failure in the context of comorbidities, particularly type 2 diabetes and chronic kidney disease. For patients with these conditions, SGLT2 inhibitors (dapagliflozin or empagliflozin) are now recommended to mitigate the risk of heart failure, hospitalization or cardiovascular death. Additionally, the use of finerenone is recommended for heart failure hospitalization risk reduction in patients with type 2 diabetes and chronic kidney disease. Intravenous iron supplementation is endorsed for symptomatic patients with heart failure and iron deficiency, aiming to alleviate symptoms and enhance their quality of life.

Dr. Marco Metro, the chairperson of the guidelines task force and director of the Institute of Cardiology of the Civil Hospital and the University of Brescia, highlighted the dynamic nature of heart failure research, necessitating a focused update to incorporate recent advancements. He emphasized that the new recommendations cover three crucial areas: chronic heart failure, acute heart failure, and comorbidities.

Professor Theresa McDonagh, the guidelines task force chairperson and consultant cardiologist at King’s College Hospital, emphasized the swift pace of developments in heart failure research. She underscored the significance of this focused update, which merges the latest evidence-based treatments with cutting-edge management recommendations, all geared towards enhancing patient outcomes.

Reference:

McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [published online ahead of print, 2023 Aug 25]. Eur Heart J. 2023;ehad195. doi:10.1093/eurheartj/ehad195

Focused update of ESC Heart Failure Guidelines published today. ESC Congress 2023. August 25, 2023. Accessed August 25, 2023. https://www.escardio.org/The-ESC/Press-Office/Press-releases/focused-update-of-esc-heart-failure-guidelines-published-today.

European Society of CardiologyEuropean Heart Journalheart failureheart failure with preserved ejection fractionheart failure with mildly reduced ejection fraction
Source : European Heart Journal
Dr. Kamal Kant Kohli
Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Show Full Article
Next Story

Editorial

How to Improve Adherence in Hypertensive Patients? Bridging the Gap with CONNECT Tool

How to Improve Adherence in Hypertensive Patients? Bridging the Gap with CONNECT Tool

Vestibular Migraine: Clinical Update and Role of Buccal Prochlorperazine

Vestibular Migraine: Clinical Update and Role of Buccal Prochlorperazine

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or Levocetirizine Use

U.S. FDA Drug Safety Alert: Warning Issued for Severe Itching After Stopping Long-Term Cetirizine or...

Aspirin in Primary Prevention: Prudent Guideline-Based Approach

Aspirin in Primary Prevention: Prudent Guideline-Based Approach

Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

Prediabetes and CKD: An Overlooked Interaction in Early Metabolic Disease

View All

Journal Club Today

New Cancer Test May Identify Who Wont Respond to Chemotherapy: Study Suggests

New Cancer Test May Identify Who Won't Respond to Chemotherapy: Study Suggests

View All

Health News Today

Health Bulletin 24/June/2025

Health Bulletin 24/June/2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok